Skip to main content
SpringerLink
Log in

Soft Drugs Based on Hydrocortisone: The Inactive Metabolite Approach and Its Application to Steroidal Antiinflammatory Agents

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The soft drug approach was applied to the design of analogs of highly potent synthetic steroids but with a metabolically labile ester group which at the same time served as an activating group.

Methods. Several structural modifications of soft antiinflammatory steroids were synthesized and tested in several assays of biological activity. The hydrolytic stability of the compounds was also determined.

Results. One of the compounds synthesized was determined to be a very potent steroid and had a highly significant separation of topical from systemic activity. However, the compound demonstrated greater than expected stability in the hydrolysis studies.

Conclusions. The goal of the soft drug approach has been achieved with the development of a highly potent drug which displays little or no systemic activity as measured in the tests presented here. The anticipated hydrolytic instability of the compounds was not corroborated; however, in view of other results, the interpretation is allowed that the rapid hydrolysis of the unbound fraction of the drug is an important factor in its lack of systemic effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. N. Bodor. Novel approaches to the design of safer drugs: Soft drugs and site-specific chemical delivery systems. Adv. Drug Res. 13:255–331 (1984).

    Google Scholar 

  2. N. Bodor, K. B. Sloan, R. J. Little, S. H. Selk, and L. Caldwell. Soft Drugs IV. 3-Spirothiazolidines of hydrocortisone and its derivatives. Int. J. Pharm. 10:307–321 (1982).

    Google Scholar 

  3. J. W. Perrine, P. H. Bell, L. Bortle, E. Heyder, E. K. Ross, and I. Ringler. The biological activity of triamcinolone, 16α-hydroxy-Δ1, 9α-fluorohydrocortisone (Aristocort) and related steroids. J. Pharmacol. Exp. Ther. 122:60A (1958).

    Google Scholar 

  4. G. J. Blackwell, R. Carnuccio, M. Di Rosa, R. J. Flower, L. Parente, and P. Persico. Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature (London) 287:147–149 (1980).

    Google Scholar 

  5. E. J. Ariëns. Modulation of Pharmacokinetics by Molecular Manipulation. Drug Design, vol II, Chapt. 1.

  6. M. Scott, L. A. Malmsten, and I. Thelin. Effect on plasma cortisol level and urinary cortisol excretion, in healthy volunteers, after application of three different topical steroid ointments under occlusion. Acta Derm.-Venereol. 61:543–6 (1981).

    Google Scholar 

  7. C. Monder and H. L. Bradlow. Cortoic acids: explorations at the frontier of corticosteroid metabolism. Recent Prog. Horm. Res. 36:345–400 (1980).

    Google Scholar 

  8. T. Loftsson and N. Bodor. Improved delivery through biological membranes X: Percutaneous absorption and metabolism of methylsulfinyl 2-acetoxybenzoate and related aspirin prodrugs. J. Pharm. Sci. 70:756–758 (1981).

    Google Scholar 

  9. W. J. Wheeler, W. E. Wright, V. D. Line, and J. A. Frogge. Orally active esters of cephalosporin antibiotics. Synthesis and biological properties of 7-(D-2-amino-2-phenylacetamido)-3-[5-methyl-(1,3, 4-thiadiazol-2-yl) thiomethyl]-3-cephem-4-carboxylic acid. J. Med. Chem. 20:1159–1164 (1977).

    Google Scholar 

  10. N. Bodor and J. J. Kaminski. Soft Drugs. 2. Soft alkylating compounds as potential antitumor agents. J. Med. Chem. 23:566–569 (1980).

    Google Scholar 

  11. H. Laurent, E. Gerhards, and R. Wiechert. Synthesis of novel antiinflammatory steroids. Angew. Chem., Int. Ed. Engl. 14:65–69 (1975).

    Google Scholar 

  12. W. Mützel. Pharmakokinetik und biotransformation von fluocortin-butylester beim menschen. Arzneim. Forsch. 27:2230–2233 (1977).

    Google Scholar 

  13. G. H. Phillipps. Locally active corticosteroids: structure-activity relationships. In L. Wilson, R Marks (eds.), Mech. Top. Corticosteroid Act., Glaxo Symp., 1974, Churchill-Livingstone, London, 1976, pp. 1–18.

    Google Scholar 

  14. D. J. Kertesz and M. Marx. Thiol esters from steroid 17α-carboxylic acids: carboxylate activation and internal participation by 17α-acylates. J. Org. Chem. 51:2315–2328 (1986).

    Google Scholar 

  15. R. J. Little. Design and synthesis of several antiinflammatory soft steroids and analysis of factors involved in the biological activities thereof. Ph.D. Thesis. University of Florida, 1983.

  16. S. M. McElvain and J. T. Venerable. Ketene Acetals. XXI. The Dealcoholation of Orthoesters. Dimethylketene Dimethyl Acetal. J. Am. Chem. Soc. 72:1661–1669 (1950).

    Google Scholar 

  17. S. Miyano and H. Hashimoto. A convenient synthesis of chloroiodomethane from dichloromethane and sodium iodide in dimethyl-formamide. Bull. Chem. Soc. Jpn. 44:2864 (1971).

    Google Scholar 

  18. R. Gardi, R. Vitali, G. Vitali, and A. Ercoli. Antiinflammatory activities of 17,21-methyl ortho esters, 17-mono-and 17,21-diesters of 6α, 9α-difluorocorticosteroids. J. Med. Chem. 15:556–558 (1972).

    Google Scholar 

  19. R. Gardi, R. Vitali, and A. Ercoli. Preparation and reaction of 17-mono esters. Gazz. Chim. Ital. 93:431–450 (1963).

    Google Scholar 

  20. J. von Euw and T. Reichstein. Über bestandteile der nebennieren-rinde und verwandte stoffe. 56. Substanz V und konfigurationsbes-timmungen in der C21O5 gruppe. Helv. Chim. Acta 25:988–1022 (1942).

    Google Scholar 

  21. P. Druzgala and N. Bodor. O-Alkylation of cortienic acid and synthesis of a new class of glucocorticoid containing a 17α-alkoxy, a 17α (1′-alkoxyethyloxy), a 17α-alkoxymethyloxy, or a 17α-methylthiomethyloxy function. Steroids 56:490–494 (1991).

    Google Scholar 

  22. B. W. Barry and R. Woodford. Activity and bioavailability of topical steroids: In vivo-in vitro correlations for the vasoconstrictor test. J. Clin. Pharm. 3:43–65 (1978).

    Google Scholar 

  23. R. O. Stafford, L. E. Barnes, B. J. Bowman, and M. M. Meinzinger. Glucocorticoid and mineralocorticoid activities of Δ1-fluorohydrocortisone. Proc. Soc. Exp. Biol. Med. 89:371 (1955).

    Google Scholar 

  24. N. R. Stephenson. The effect of corticosteroid analogues on the thymus gland of the immature rat. J. Pharm. Pharmacol. 12:411–415 (1960).

    Google Scholar 

  25. R. Meier, W. Schuler, and P. Desaulles. Zur frage der mechanismus der hemmung des bindegewebswachstums durch cortisone. Experentia 6:469–471 (1950).

    Google Scholar 

  26. N. Bodor, T. Loftsson, and W.-M. Wu. Metabolism, distribution, and transdermal permeation of a soft corticosteroid, Loteprednol Etabonate. Pharm. Res. 9:1275–1278 (1992).

    Google Scholar 

  27. G. Hochhaus, L.-S. Chen, A. Ratka, P. Druzgala, J. Howes, N. Bodor, and H. Derendorf. Pharmacokinetic characterization and tissue distribution of the new glucocorticoid soft drug, Loteprednol Etabonate in rats and dogs. J. Pharm. Sci. 81:1210–1215 (1992).

    Google Scholar 

  28. K. B. Sloan and J. H. Perrin. Comments concerning ‘Pharmacokinetic characterization and tissue distrubution of the new glucocorticoid soft drug, Loteprednol Etabonate in rats and dogs.’ J. Pharm. Sci. 83:1066 (1994).

    Google Scholar 

  29. G. Hochhaus, P. Druzgala, J. F. Howes, N. Bodor, and H. Derendorf. Response to the commentary on ‘Pharmacokinetic characterization and tissue distrubution of the new glucocorticoid soft drug, Loteprednol Etabonate in rats and dogs.’ J. Pharm. Sci. 83:1067 (1994).

    Google Scholar 

  30. H. Schmidli. Multivariate prediction for QSAR. Chemom. Intell. Lab. Syst. 37:125–134 (1997).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chemistry, Universidad de los Andes, Mérida, Venezuela

    Roy J. Little

  2. Center for Drug Discovery, College of Pharmacy, University of Florida, Gainesville, Florida

    Nicholas Bodor

  3. Department of Pharmacy, University of Iceland, IS-101, Reykjavik, Iceland

    Thorsteinn Loftsson

Authors
  1. Roy J. Little
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicholas Bodor
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thorsteinn Loftsson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roy J. Little.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Little, R.J., Bodor, N. & Loftsson, T. Soft Drugs Based on Hydrocortisone: The Inactive Metabolite Approach and Its Application to Steroidal Antiinflammatory Agents. Pharm Res 16, 961–967 (1999). https://doi.org/10.1023/A:1018907026460

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018907026460

Search

Navigation